Jianxin Wang

3.5k total citations · 1 hit paper
85 papers, 2.7k citations indexed

About

Jianxin Wang is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Jianxin Wang has authored 85 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Biomedical Engineering, 21 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Jianxin Wang's work include Bone Tissue Engineering Materials (13 papers), Nanoplatforms for cancer theranostics (11 papers) and Immune cells in cancer (9 papers). Jianxin Wang is often cited by papers focused on Bone Tissue Engineering Materials (13 papers), Nanoplatforms for cancer theranostics (11 papers) and Immune cells in cancer (9 papers). Jianxin Wang collaborates with scholars based in China, United States and South Korea. Jianxin Wang's co-authors include Zhi Wang, Jianhua Xiao, Li Li, Wenmiao Chen, Shijin Shuai, Fujia Wu, Jie Weng, Xiong Lu, Emily S. Day and Bo Feng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jianxin Wang

83 papers receiving 2.7k citations

Hit Papers

Depletion of tumor associated macrophages enhances local ... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianxin Wang China 26 1.4k 638 508 470 463 85 2.7k
Tetsuharu Narita France 30 806 0.6× 479 0.8× 179 0.4× 82 0.2× 355 0.8× 105 2.8k
Tatsuhiro Takahashi Japan 33 581 0.4× 323 0.5× 389 0.8× 74 0.2× 845 1.8× 186 3.2k
Masataka Sugimoto Japan 30 189 0.1× 1.6k 2.5× 385 0.8× 382 0.8× 128 0.3× 135 3.6k
Mukesh Kumar Gupta United States 29 1.1k 0.8× 894 1.4× 51 0.1× 129 0.3× 320 0.7× 109 3.0k
Christian Gorzelanny Germany 28 455 0.3× 604 0.9× 56 0.1× 481 1.0× 217 0.5× 64 2.8k
Jianli Wang China 26 336 0.2× 842 1.3× 21 0.0× 523 1.1× 484 1.0× 132 2.8k
Zhijie Ma China 27 774 0.6× 262 0.4× 64 0.1× 32 0.1× 470 1.0× 72 2.5k
Morihiko Nakamura Japan 29 137 0.1× 518 0.8× 103 0.2× 436 0.9× 1.1k 2.3× 149 2.8k
Tong Gao China 28 488 0.4× 169 0.3× 88 0.2× 82 0.2× 829 1.8× 83 2.5k
Hector Lopez Hernandez United States 22 866 0.6× 296 0.5× 20 0.0× 159 0.3× 222 0.5× 33 2.4k

Countries citing papers authored by Jianxin Wang

Since Specialization
Citations

This map shows the geographic impact of Jianxin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxin Wang more than expected).

Fields of papers citing papers by Jianxin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianxin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxin Wang. The network helps show where Jianxin Wang may publish in the future.

Co-authorship network of co-authors of Jianxin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianxin Wang. A scholar is included among the top collaborators of Jianxin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianxin Wang. Jianxin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Nan, Keyu Li, Jun-Ke Wang, et al.. (2025). Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer. Biomarker Research. 13(1). 21–21. 2 indexed citations
2.
Qiu, Qiujun, Shiyi Li, Jixian Zhang, et al.. (2025). Lab-in-the-loop machine learning for brain-targeting delivery system design. 1(9). 100130–100130. 4 indexed citations
3.
Chen, Xiangli, Linyu Wang, Yuancong Zhao, et al.. (2024). Surface State-Based panchromatic luminescent carbon dots. Journal of Colloid and Interface Science. 678(Pt A). 77–87. 17 indexed citations
4.
Sang, Junkang, Jun Yang, Yang Zhang, et al.. (2024). Reversible operation of solid oxide cells fed with syngas derived from underground coal gasification. International Journal of Hydrogen Energy. 79. 1456–1463. 3 indexed citations
5.
Lv, Jingwei, Jianxin Wang, Lin Yang, et al.. (2024). Recent advances of optical fiber biosensors based on surface plasmon resonance: sensing principles, structures, and prospects. Sensors & Diagnostics. 3(9). 1369–1391. 31 indexed citations
8.
Zhao, Sheng, Jianxin Wang, Shiyu Lu, et al.. (2023). Facile Synthesis of Basic Copper Carbonate Nanosheets for Photoacoustic Imaging-Guided Tumor Apoptosis and Ferroptosis and the Extension Exploration of the Synthesis Method. ACS Applied Materials & Interfaces. 15(36). 42317–42328. 3 indexed citations
9.
Wang, Jianxin, Wei Liu, Lin Yang, et al.. (2023). Symmetrical dual D-shape fiber for waveguide coupled surface plasmon resonance sensing. Optik. 287. 171162–171162. 1 indexed citations
10.
Jeong, Woo‐Jin, Jiyoon Bu, Yanxiao Han, et al.. (2022). Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions between SARS-CoV-2 Spike Protein and Human ACE2 Receptor. Biomacromolecules. 24(1). 141–149. 7 indexed citations
11.
Wang, Jianxin, et al.. (2022). Isocorrole-Loaded Polymer Nanoparticles for Photothermal Therapy under 980 nm Light Excitation. ACS Omega. 7(41). 36653–36662. 12 indexed citations
12.
Rawding, Piper A., Jiyoon Bu, Jianxin Wang, et al.. (2021). Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 14(2). e1752–e1752. 31 indexed citations
13.
Wang, Jianxin, Adam J. Drelich, Sandro Mecozzi, et al.. (2021). Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS‐CoV‐2 testing development. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 14(1). e1754–e1754. 55 indexed citations
14.
He, Xuedan, Melissa Dolan, Yuhao Shi, et al.. (2021). Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model. Journal for ImmunoTherapy of Cancer. 9(12). e003101–e003101. 20 indexed citations
15.
Yu, Zhili, Xiaojuan Zhang, Junxiao Ye, et al.. (2021). Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA. International Journal of Pharmaceutics. 606. 120940–120940. 33 indexed citations
16.
Wang, Jianxin, et al.. (2019). Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies. ACS Omega. 5(1). 926–940. 69 indexed citations
17.
Wang, Jianxin, Mini Thomas, Peng Lin, et al.. (2018). siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods. Bioconjugate Chemistry. 30(2). 443–453. 20 indexed citations
18.
Shi, Haitang, Meng Niu, Longfei Tan, et al.. (2015). A smart all-in-one theranostic platform for CT imaging guided tumor microwave thermotherapy based on IL@ZrO2nanoparticles. Chemical Science. 6(8). 5016–5026. 73 indexed citations
19.
Li, Li, Jianxin Wang, Jianhua Xiao, Zhi Wang, & Yang Wenming. (2014). Particulate emission characteristics of vehicle diesel engine fuelled with palm-oil derived biodiesel. China Environmental Science. 34(10). 2458–2465. 2 indexed citations
20.
Wang, Xuefeng, Jing Ma, Jianxin Wang, et al.. (2014). Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. Retrovirology. 11(1). 26–26. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026